The down-regulation of TLR4 in patients with MMR gene deficient CRC may add a further explanation of chemoresistance of MSI-H CRC besides the effect of miRNA-21 on MSH2 (Valeri et al., 2010a). The gene discussed is MSH2; the disease is colorectal carcinoma.